HIV infected scope for TEE procedure, patient sues St. Vincent's Hospital

Milvia Lopez, by her attorney MICHAEL STEWART FRANKEL, of New York City, recently filed suit, in Supreme Court, New York County, bearing Index # 112888/2009. The complaint alleges that while Ms. Lopez underwent a routine transesophageal echocardiogram ("TEE") at ST. VINCENT'S HOSPITAL, doctors used an HIV infected scope exposing her to HIV.

The complaint alleges that several hours after being discharged from the procedure and arriving back at her home, Ms. Lopez received a phone call from an employee of ST. VINCENT'S HOSPITAL in which she was asked to urgently return to the hospital. Upon returning to ST. VINCENT'S HOSPITAL by means of a limousine provided by the hospital, Ms. Lopez was told that non-sterile equipment had been used by ST. VINCENT'S HOSPITAL during her TEE procedure. It is alleged that Ms. Lopez was advised that she had been exposed to HIV, Hepatitis B and Hepatitis C due to the use of the non-sterile equipment during her procedure. This resulted in Ms. Lopez undergoing anti HIV treatment. Ms. Lopez is seeking compensatory and punitive damages.

The complaint also alleges concealment of records by the hospital.

Source:

The Michael Stewart Frankel Law Firm

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug